Thomas A. Wynn

VP of Discovery, Pfizer at Capstan Therapeutics

Thomas A. Wynn, Ph.D. is Vice President of Discovery in the Inflammation and Immunology Research Unit at Pfizer where he leads a team of scientists focusing on autoimmune, inflammatory, and fibrotic diseases in the areas Rheumatology, Dermatology, and Gastroenterology. Prior to joining Pfizer, he was Senior Investigator and Chief of the Immunopathogenesis Section at the National Institute of Allergy and Infectious Diseases, NIH, where he and his team focused on type 2 cytokine-driven inflammatory diseases and mechanisms of fibrosis in various organ systems, including liver, intestine, and lung.